A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Exclusion Criteria

• •Patient may not meet any of the excluded conditions specified in the protocol
• •Patient has any alarm symptoms including but not limited to GI bleeding, anemia, vomiting, dysphagia, or unexpected weight loss any time during the Screening or Pretreatment Periods
• •Patient has a history of clinically significant hypersensitivity or allergies to any of the excipients contained in the study medication (active or placebo).